95 related articles for article (PubMed ID: 29029037)
1. Functional variants in the low-density lipoprotein receptor gene are associated with clear cell renal cell carcinoma susceptibility.
Zhang GM; Wang MY; Liu YN; Zhu Y; Wan FN; Wei QY; Ye DW
Carcinogenesis; 2017 Dec; 38(12):1241-1248. PubMed ID: 29029037
[TBL] [Abstract][Full Text] [Related]
2. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
3. Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.
Qin C; Chen J; Li J; Ju X; Zhang S; Cao Q; Han Z; Li P; Shao P; Wang M; Zhang Z; Gu M; Zhang W; Yin C
Mutagenesis; 2014 Nov; 29(6):419-25. PubMed ID: 25239121
[TBL] [Abstract][Full Text] [Related]
4. Effect of a functional polymorphism in the pre-miR-146a gene on the risk and prognosis of renal cell carcinoma.
Huang Z; Lu Z; Tian J; Wang G; Gao Z
Mol Med Rep; 2015 Nov; 12(5):6997-7004. PubMed ID: 26323945
[TBL] [Abstract][Full Text] [Related]
5. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
6. Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population.
Partyka A; Tupikowski K; Kolodziej A; Zdrojowy R; Halon A; Malkiewicz B; Dembowski J; Frydecka I; Karabon L
Urol Oncol; 2016 Sep; 34(9):419.e13-9. PubMed ID: 27234378
[TBL] [Abstract][Full Text] [Related]
7. LDLR promotes growth and invasion in renal cell carcinoma and activates the EGFR pathway.
Zhang GM; Chen W; Yao Y; Luo L; Sun LJ
Neoplasma; 2022 Jan; 69(1):113-122. PubMed ID: 34846158
[TBL] [Abstract][Full Text] [Related]
8. miR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: a case-control study.
Wang Z; Wei M; Ren Y; Liu H; Wang M; Shi K; Jiang H
Tumour Biol; 2014 Dec; 35(12):12127-30. PubMed ID: 25213695
[TBL] [Abstract][Full Text] [Related]
9. XRCC3 Thr241Met and XPD Lys751Gln gene polymorphisms and risk of clear cell renal cell carcinoma.
Loghin A; Bănescu C; Nechifor-Boila A; Chibelean C; Orsolya M; Nechifor-Boila A; Tripon F; Voidazan S; Borda A
Cancer Biomark; 2016; 16(2):211-7. PubMed ID: 26682510
[TBL] [Abstract][Full Text] [Related]
10. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract][Full Text] [Related]
12. A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding.
Wang Y; Yang ZY; Chen YH; Li F; Shen H; Yu Y; Huang HY; Shen ZY
J Cell Mol Med; 2018 Jun; 22(6):3005-3015. PubMed ID: 29569387
[TBL] [Abstract][Full Text] [Related]
13. ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.
Zhang G; Gu C; Zhu Y; Luo L; Dong D; Wan F; Zhang H; Shi G; Sun L; Ye D
Cancer Sci; 2015 Jun; 106(6):687-691. PubMed ID: 25827778
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein-3 (IGFBP-3) gene variants are associated with renal cell carcinoma.
Safarinejad MR
BJU Int; 2011 Sep; 108(5):762-70. PubMed ID: 21314884
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
[TBL] [Abstract][Full Text] [Related]
16. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
[TBL] [Abstract][Full Text] [Related]
17. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
[TBL] [Abstract][Full Text] [Related]
19. Combined Genotype Analyses of Precursor miRNA196a2 and 499a Variants with Hepatic and Renal Cancer Susceptibility a Preliminary Study.
Toraih EA; Fawz MS; Elgazzaz MG; Hussein MH; Shehata RH; Daoud HG
Asian Pac J Cancer Prev; 2016; 17(7):3369-75. PubMed ID: 27509977
[TBL] [Abstract][Full Text] [Related]
20. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
